Literature DB >> 18111349

A fundus dystrophy with unusual features.

A SORSBY, M E J MASON.   

Abstract

Entities:  

Keywords:  RETINA/diseases

Mesh：

Year:  1949        PMID： 18111349      PMCID： PMC510908          DOI： 10.1136/bjo.33.2.67

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  47 in total

Review 1.  Matrix metalloproteinase biology applied to vitreoretinal disorders.

Authors:  C S Sethi; T A Bailey; P J Luthert; N H Chong
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Probable common origin of a hereditary fundus dystrophy (Sorsby's familial pseudoinflammatory macular dystrophy) in an English and Australian family.

Authors:  H Kalmus; D Seedburgh
Journal:  J Med Genet       Date:  1976-08       Impact factor: 6.318

3.  Clinical features of a novel TIMP-3 mutation causing Sorsby's fundus dystrophy: implications for disease mechanism.

Authors:  M Clarke; K W Mitchell; J Goodship; S McDonnell; M D Barker; I D Griffiths; N McKie
Journal:  Br J Ophthalmol       Date:  2001-12       Impact factor: 4.638

4.  Successful photodynamic therapy for subretinal neovascularisation due to Sorsby's fundus dystrophy: 1 year follow up.

Authors:  S C Wong; K C S Fong; N Lee; K Gregory-Evans; C Y Gregory-Evans
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

5.  Sorsby fundus dystrophy presenting with choroidal neovascularisation showing good response to steroid treatment.

Authors:  D Atan; C Y Gregory Evans; D Louis; S M Downes
Journal:  Br J Ophthalmol       Date:  2004-03       Impact factor: 4.638

6.  A novel TIMP3 mutation associated with a retinitis pigmentosa-like phenotype.

Authors:  Meghan J DeBenedictis; Yosef Gindzin; Enrico Glaab; Bela Anand-Apte
Journal:  Ophthalmic Genet       Date:  2020-07-27       Impact factor: 1.803

7.  Tissue inhibitor of metalloproteinase-3 differentially binds to components of Bruch's membrane.

Authors:  M A Majid; V A Smith; F J Matthews; A C Newby; A D Dick
Journal:  Br J Ophthalmol       Date:  2006-07-12       Impact factor: 4.638

8.  Matrix bound SFD mutant TIMP-3 is more stable than wild type TIMP-3.

Authors:  Mohammed A Majid; Valerie A Smith; Andrew C Newby; Andrew D Dick
Journal:  Br J Ophthalmol       Date:  2007-03-23       Impact factor: 4.638

9.  OCULAR LESIONS OF ONCHOCERCIASIS.

Authors:  F H Budden
Journal:  Br J Ophthalmol       Date:  1962-01       Impact factor: 4.638

10.  Tissue inhibitor of matrix metalloproteinase-3 levels in the extracellular matrix of lung, kidney, and eye increase with age.

Authors:  Anne M Macgregor; Charles G Eberhart; Mostafa Fraig; Jie Lu; Marc K Halushka
Journal:  J Histochem Cytochem       Date:  2008-10-27       Impact factor: 2.479
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.